Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.43 |
| ▸ | KDM4A | O75164 | 2/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.43 |
| ▸ | TET3 | O43151 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 7/20 | 0.41 |
| ▸ | GABRP | O00591 | 2/20 | 0.41 |
| ▸ | GABRD | O14764 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.41 |
| ▸ | GABRE | P78334 | 2/20 | 0.41 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6311082 | 1.00 | CYP1A2 (0.46) | CYP1A2TET2KDM4AKDM4CKDM2A | |
| Hydrochloric Acid SCHEMBL9432688 | 0.98 | CYP1A2 (0.45) | CYP1A2TET2KDM4AKDM4CKDM2A | |
| Hydrochloric Acid SCHEMBL573426 | 0.98 | CYP1A2 (0.45) | CYP1A2TET2KDM4AKDM4CKDM2A | |
| SCHEMBL28616559 | 0.86 | HTR2A (0.40) | CYP1A2GRIK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL27009252 | 0.85 | GABRP (0.40) | CYP1A2TET2KDM4AKDM4CKDM2A | |
| SCHEMBL11344676 | 0.84 | FFAR4 (0.50) | ALDH1A1 | |
| SCHEMBL2244866 | 0.83 | KMT2A (0.47) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL27774327 | 0.83 | KMT2A (0.47) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL5988400 | 0.83 | KMT2A (0.47) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL11551742 | 0.83 | CYP1A2 (0.43) | CYP1A2TET2KDM4AKDM4CKDM2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522747-B2 | Coating compositions for use in creped paper product manufacturing and methods for producing the same | SOLENIS TECHNOLOGIES, L.P. (US) | 2026-01-13 | — | — | US | claimed |
| US-20230193076-A1 | COATING COMPOSITIONS FOR USE IN CREPED PAPER PRODUCT MANUFACTURING AND METHODS FOR PRODUCING THE SAME | SOLENIS TECHNOLOGIES, L.P. (US) | 2023-06-22 | — | — | US | claimed |
| EP-0846111-B1 | SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES | AGOURON PHARMA (US) | 2003-08-27 | — | — | EP | claimed |
| EP-0705094-B1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | CARSON PROD CO (US) | 2000-05-24 | — | — | EP | claimed |
| EP-3804725-A2 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | Rhode Island Hospital (US) | 2021-04-14 | — | — | EP | disclosed |
| EP-2654665-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012083906-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2012-06-28 | — | — | WO | disclosed |
| US-5698556-A | TREATING CANCER | CHAN CARCY L (US) | 1997-12-16 | — | — | US | disclosed |